Dyspepsia (Indigestion) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Dyspepsia (Indigestion) – Drugs In Development, 2024 report and make more profitable business decisions.
Indigestion is a group of gastrointestinal symptoms that occur together, including pain, a burning feeling, or discomfort in the upper abdomen; feeling full too soon while eating; and feeling uncomfortable after eating. Treatment for indigestion depends on the cause and may include medicines, changes in what you eat and drink, psychological therapies, and lifestyle changes.
The Dyspepsia (Indigestion) drugs in development market research report provide comprehensive information on the therapeutics under development for Dyspepsia (Indigestion), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dyspepsia (Indigestion) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Dyspepsia (Indigestion) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 11 molecules, with 9 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Dyspepsia (Indigestion) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Dyspepsia (Indigestion) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Dyspepsia (Indigestion) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Dong-A ST Co LtdFaes Farma SA
ISOThrive Inc
Kyungpook National University
Meiji Seika Pharma Co Ltd
Mitsubishi Tanabe Pharma Corp
RaQualia Pharma Inc
Renexxion LLC
Sebela Pharmaceuticals Inc
Sinovant Sciences HK Ltd
Technical University of Munich
TSH Biopharm Corporation Ltd
Vanda Pharmaceuticals Inc
Zeria Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Dyspepsia (Indigestion) reports